These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17765993)

  • 1. Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses.
    Opitz L; Lehmann S; Zimmermann A; Reichl U; Wolff MW
    J Biotechnol; 2007 Sep; 131(3):309-17. PubMed ID: 17765993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses.
    Opitz L; Salaklang J; Büttner H; Reichl U; Wolff MW
    Vaccine; 2007 Jan; 25(5):939-47. PubMed ID: 17011087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles.
    Opitz L; Lehmann S; Reichl U; Wolff MW
    Biotechnol Bioeng; 2009 Aug; 103(6):1144-54. PubMed ID: 19449393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent.
    Opitz L; Zimmermann A; Lehmann S; Genzel Y; Lübben H; Reichl U; Wolff MW
    J Virol Methods; 2008 Dec; 154(1-2):61-8. PubMed ID: 18840469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography.
    Opitz L; Hohlweg J; Reichl U; Wolff MW
    J Virol Methods; 2009 Nov; 161(2):312-6. PubMed ID: 19591872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium.
    He C; Yang Z; Tong K
    J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
    Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
    J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.
    Vester D; Rapp E; Gade D; Genzel Y; Reichl U
    Proteomics; 2009 Jun; 9(12):3316-27. PubMed ID: 19504497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downstream processing of MDCK cell-derived equine influenza virus.
    Nayak DP; Lehmann S; Reichl U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):75-81. PubMed ID: 16009601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines.
    Kalbfuss B; Genzel Y; Wolff M; Zimmermann A; Morenweiser R; Reichl U
    Biotechnol Bioeng; 2007 May; 97(1):73-85. PubMed ID: 16921531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification.
    Wickramasinghe SR; Kalbfuss B; Zimmermann A; Thom V; Reichl U
    Biotechnol Bioeng; 2005 Oct; 92(2):199-208. PubMed ID: 16041807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin.
    Schwarzer J; Rapp E; Hennig R; Genzel Y; Jordan I; Sandig V; Reichl U
    Vaccine; 2009 Jul; 27(32):4325-36. PubMed ID: 19410619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type and subtype distribution of influenza virus and genetic evolution of hemagglutinin in Shanghai area in duration of 2004 - 2008].
    Yang JX; Ju LW; Jiang LF; Shi Q; Jiang QW; Zhang YY; Zhou YB; Shen HG; Tan YY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Apr; 43(4):305-8. PubMed ID: 19534952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of influenza virus hemagglutinin in process samples using weak affinity ligands and surface plasmon resonance.
    Mandenius CF; Wang R; Aldén A; Bergström G; Thébault S; Lutsch C; Ohlson S
    Anal Chim Acta; 2008 Aug; 623(1):66-75. PubMed ID: 18611459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization and phylogenetic analysis of H1N1 and H3N2 human influenza A viruses among infants and children in Thailand.
    Chutinimitkul S; Chieochansin T; Payungporn S; Samransamruajkit R; Hiranras T; Theamboonlers A; Poovorawan Y
    Virus Res; 2008 Mar; 132(1-2):122-31. PubMed ID: 18160168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of cell culture-derived modified vaccinia ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography.
    Wolff MW; Siewert C; Hansen SP; Faber R; Reichl U
    Biotechnol Bioeng; 2010 Oct; 107(2):312-20. PubMed ID: 20506129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of human influenza virus in Tehran, Iran.
    Soltani Z; Hosseini M; Shahidi M; Hedayati M; Kheiri MT
    Intervirology; 2009; 52(2):63-7. PubMed ID: 19401630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a strategy of influenza virus separation based on pseudoaffinity chromatography on short monolithic columns.
    Kalashnikova I; Ivanova N; Tennikova T
    Anal Chem; 2008 Mar; 80(6):2188-98. PubMed ID: 18271603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France.
    Falchi A; Arena C; Andreoletti L; Jacques J; Leveque N; Blanchon T; Lina B; Turbelin C; Dorléans Y; Flahault A; Amoros JP; Spadoni G; Agostini F; Varesi L
    J Clin Virol; 2008 Feb; 41(2):148-51. PubMed ID: 18069055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.